Chronic Paroxysmal Hemicrania in a 3-Year, 10-Month-Old Female

Talvik, Inga; Koch, Kadri; Kolk, Anneli; Talvik, Tiina

doi:10.1016/j.pediatrneurol.2005.08.026

Cited by 23 publications

(19 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…PH is considered rare in children, although actual data are lacking . Thirteen case reports of 22 children with PH (including an 8+2+2 series) were identified from the English literature in a Pubmed search on October 24, 2018 . The present case showed the shortest course of any of these cases of pediatric PH.…”

Section: Discussionmentioning

confidence: 67%

Case Report: Shortest Course of Pediatric Paroxysmal Hemicrania

et al. 2019

View full text Add to dashboard Cite

Paroxysmal hemicrania (PH) is a rare primary headache disorder, especially among children. We describe herein a case with the shortest course of pediatric PH among previously reported cases, and the first case report of Japanese pediatric PH. An 11‐year‐old boy was referred to our clinic by his primary care physician for a headache evaluation. He had been complaining of severe, sharp, pulsating headache for 5 days. Attacks were restricted to the left side with a duration ranging from 2 to 20 minutes, 20‐30 times a day. Attacks were associated with left autonomic symptoms (conjunctival injection, lacrimation, nasal congestion, eyelid edema, and ptosis). Two days after we prescribed indomethacin at 0.9 mg/kg/day, the patient was headache free. He stopped taking indomethacin 14 days after consultation because of drug eruptions. As of the time of writing, more than 1 year later, he has experienced no recurrence of headache. This case indicates the importance of improving awareness among general doctors regarding PH in children, and of conducting further investigations about low‐dose, short‐term indomethacin treatment.

show abstract

Section: Discussionmentioning

confidence: 67%

Case Report: Shortest Course of Pediatric Paroxysmal Hemicrania

et al. 2019

View full text Add to dashboard Cite

show abstract

“…In the ICHD-II, there is a considerable overlapping between the diagnostic criteria for CPH and CH, mostly concerning headache duration (from 15 to 30 min) and attack frequency (from 5 to 8), thus complicating the differential diagnosis. Moreover, also the behavioural characteristics may not be useful in distinguishing CPH from CH, since agitation, restlessness and aggressive behaviour during pain attacks, typical of CH [20], have been described also in some CPH cases [7, 12]. Pain site and associated autonomic phenomena are similar in both headaches, but the higher frequency of the attacks, their shorter duration and the absolute response to indomethacin may help in distinguishing CPH from CH [3].…”

Section: Discussionmentioning

confidence: 99%

“…The disease can occur, although more rarely, also in children [8–16], as early as from the age of 3 [9, 12]. However, few reports in paediatric age fulfilled the diagnostic criteria for CPH [9, 10, 12] according to the International Classification of Headache Disorders, 2nd edition (ICHD-II) [3] (Table 2). In particular, the presence of autonomic signs and response to indomethacin has not been discussed adequately [11, 14, 15, 18].…”

Section: Introductionmentioning

confidence: 99%

Chronic paroxysmal hemicrania in paediatric age: report of two cases

et al. 2011

View full text Add to dashboard Cite

Chronic paroxysmal hemicrania (CPH) is a rare primary headache syndrome, which is classified along with hemicrania continua and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) as trigeminal autonomic cephalalgia (TACs). CPH is characterised by short-lasting (2–30 min), severe and multiple (more than 5/day) pain attacks. Headache is unilateral, and fronto-orbital-temporal pain is combined with cranial autonomic symptoms. According to the International Classification of Headache Disorders, 2nd edition, the attacks are absolutely responsive to indomethacin. CPH has been only rarely and incompletely described in the developmental age. Here, we describe two cases concerning a 7-year-old boy and a 11-year-old boy with short-lasting, recurrent headache combined with cranial autonomic features. Pain was described as excruciating, and was non-responsive to most traditional analgesic drugs. The clinical features of our children’s headache and the positive response to indomethacin led us to propose the diagnosis of CPH. Therefore, our children can be included amongst the very few cases of this trigeminal autonomic cephalgia described in the paediatric age.

show abstract

“…Alle trigeminoautonomenKopfschmerzformen desE rwachsenenalters sind auch für dasK indes-und Jugendalter beschrieben worden, diess ind derC lusterkopfschmerz (40, 52,5 5, 106, 109, 134, 136), die Paroxysmale Hemikranie ( 13,44,72,97,107,116,180,189,198) und dasS UNCT-Syndrom (Short-lasting unilateralneuralgiform headachea ttacksw ith conjunctivali njection andtearing) (27,43,178); auch einF all desSUNA-Syndroms (Short-Lasting unilateraln euralgiformh eadachea ttacksw ith craniala utonomic symptoms)i st für das Kindesalter beschriebenw orden (212). Die Prävalenzd ieser Kopfschmerzen im Kindes-undJ ugendalter,s owohl absolut als auch in Relation zumErwachsenenalter, ist nicht untersucht.…”

Section: Trigeminoautonomekopfschmerzenunclassified

Therapie idiopathischer Kopfschmerzen im Kindes- und Jugendalter

Kropp¹,

Pothmann²,

Heinen³

et al. 2008

Nervenheilkunde

View full text Add to dashboard Cite

ZusammenfassungNach den Richtlinien der Evidence Based Medicine sind die spezifischen kontrollierten Studien für die Behandlung von idiopathischen Kopfschmerzen im Kindes- und Jugendalter analysiert und in Therapieempfehlungen zusammengefasst worden. Mit der höchsten Evidenz wird für die Behandlung akuter Migräneattacken oder von Kopfschmerzen vom Spannungstyp Ibuprofen empfohlen. Als Mittel der zweiten Wahl wird für alle Altersstufen Paracetamol empfohlen, ab dem 12. Lebensjahr ist für Migräneattacken auch Sumatriptan Nasenspray Mittel der zweiten Wahl (im Einzelfall kann es auch bei jüngeren Kindern eingesetzt werden). Bei Versagen der Akutmedikamente der ersten und zweiten Wahl werden als Ausweichsubstanzen der dritten Wahl Zolmitriptan als Schmelztablette, Zolmitriptan als Nasenspray, Rizatriptan, Almotriptan und Dihydroergotamin empfohlen. Für die medikamentöse Prophylaxe der Migräne werden Magnesium, Betablocker (Propranolol oder Metoprolol) und Flunarizin empfohlen. Flunarizin ist auch prophylaktisches Mittel der ersten Wahl bei migräneähnlichen Syndromen. Für andere Kopfschmerzarten liegen keine kontrollierten Studien für das Kindesalter vor. In der nicht medikamentösen Prophylaxe von Kopfschmerzen im Kindesalter werden mit höchster Evidenz Entspannungsverfahren (progressive Muskelrelaxation), Biofeedbackverfahren und kindgerechte kognitiv-verhaltensorientierte Therapieprogramme empfohlen.

show abstract

Chronic Paroxysmal Hemicrania in a 3-Year, 10-Month-Old Female

Cited by 23 publications

References 10 publications

Case Report: Shortest Course of Pediatric Paroxysmal Hemicrania

Case Report: Shortest Course of Pediatric Paroxysmal Hemicrania

Chronic paroxysmal hemicrania in paediatric age: report of two cases

Therapie idiopathischer Kopfschmerzen im Kindes- und Jugendalter

Contact Info

Product

Resources

About